Table 1.
MnP treatment exhibits minimal toxicity.
| Analyte | Lean | HFD | HFD + MnP | One-Way ANOVA |
|---|---|---|---|---|
| Albumin (g/dL) | 2.617 | 3.433 | 4.233 | * Lean vs. HFD + MnP |
| Alanine Aminotransferase (U/L) | 63 | 58.33 | 79 | ns |
| Alkaline Phosphatase (U/L) | 55.17 | 54.5 | 54 | ns |
| Amylase (U/L) | 921.5 | 1042 | 1092 | ns |
| Blood Urea Nitrogen (mg/dL) | 23.17 | 19.67 | 22.5 | ns |
| Calcium (mg/dL) | 10.5 | 10.18 | 10.32 | ns |
| Creatinine (mg/dL) | 0.1667 | 0.2 | 0.2 | ns |
| Globulin (g/dL) | 2.167 | 2.317 | 1.85 | ns |
| Glucose (mg/dL) | 121.5 | 141.5 | 142.2 | ns |
| Phosphorus (mg/dL) | 8.75 | 8.083 | 7.833 | ns |
| Potassium (mmol/L) | 5.583 | 5.083 | 4.633 | ns |
| Sodium (mmol/L) | 151.5 | 150.8 | 152.5 | ns |
| Total Bilirubin (mg/dL) | 0.1833 | 0.2333 | 0.2333 | ns |
| Total Serum Protein (g/dL) | 5.817 | 5.733 | 6.067 | ns |
MnP treatment exhibits minimal toxicity, n = 5 mice per group. Significance was calculated based on mean and SD by one-way ANOVA, with a Tukey post-test of multiple comparisons. * indicates p ≤ 0.05.